Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

322
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
322
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

421
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
421
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

23
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
23
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

190
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
190
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

311
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
311
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

231
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
231

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor necrosis factor inhibitor-associated IgA nephropathy in the setting of Behçet's disease: Lessons for the clinical nephrologist.

Journal of nephrology·2026
Same author

Female participation in randomized controlled trials of motor rehabilitation after spinal cord injury: a systematic review.

Spinal cord·2026
Same author

Paraneoplastic Immunoglobulin A Vasculitis With Rapidly Progressive Glomerulonephritis in a Patient With Metastatic Meningioma: Case Report and Literature Review.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2026
Same author

New proteomic biomarkers identified in plasma extracellular vesicles in sarcoidosis: a case-control matched study.

Frontiers in immunology·2026
Same author

Post-nephrectomy outcomes in COVID-19 and non-COVID-19 Patients using ACEi, ARB and SGLT2i: a N3C database study.

International urology and nephrology·2026
Same author

Sarcoidosis: Disease mechanisms, diagnostic pathway and treatment.

Autoimmunity reviews·2026

Related Experiment Video

Updated: Sep 4, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.2K

Renal sarcoidosis.

Swati Mehta1, Andrea Lightle1, Marc A Judson1

  • 1Albany Medical Center, Albany, NY, USA.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
|July 22, 2022
PubMed
Summary
This summary is machine-generated.

Renal sarcoidosis (RS) is a rare kidney disease causing granulomatous inflammation. Early diagnosis and corticosteroid treatment are key for managing RS and preventing end-stage renal disease (ESRD).

Keywords:
acute kidney injurychronic kidney diseaseend-stage renal diseaseproteinuriarenal sarcoidosis

More Related Videos

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

537
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.9K

Related Experiment Videos

Last Updated: Sep 4, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.2K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

537
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.9K

Area of Science:

  • Nephrology
  • Immunology
  • Pathology

Background:

  • Renal sarcoidosis (RS) is a rare manifestation of sarcoidosis characterized by granulomatous inflammation of the kidney.
  • It often presents with renal insufficiency or systemic inflammation, though end-stage renal disease (ESRD) is uncommon initially.

Purpose of the Study:

  • To provide a comprehensive overview of renal sarcoidosis.
  • To discuss its epidemiology, pathogenesis, clinical features, diagnosis, treatment, and outcomes.

Main Methods:

  • Review of existing literature on renal sarcoidosis.
  • Analysis of diagnostic criteria and pathological findings.
  • Evaluation of treatment strategies and patient outcomes.

Main Results:

  • RS most commonly appears at the onset of sarcoidosis but can occur anytime.
  • Renal biopsy showing interstitial non-caseating granulomas is crucial but requires exclusion of other causes.
  • Corticosteroids are the primary treatment, with most patients responding well, though long-term therapy may be needed.

Conclusions:

  • Renal sarcoidosis diagnosis should be suspected in patients with renal failure and sarcoidosis or suggestive extra-renal signs.
  • While generally responsive to corticosteroids, RS can be chronic, necessitating ongoing immunosuppression.
  • Progression to ESRD is rare.